Experimental medical mycological research in Latin America - a 2000-2009 overview.

Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela.
Revista iberoamericana de micología 12/2010; 28(1):1-25. DOI: 10.1016/j.riam.2010.11.004
Source: PubMed

ABSTRACT An overview of current trends in Latin American Experimental Medical Mycological research since the beginning of the 21(st) century is done (search from January 2000 to December 2009). Using the PubMed and LILACS databases, the authors have chosen publications on medically important fungi which, according to our opinion, are the most relevant because of their novelty, interest, and international impact, based on research made entirely in the Latin American region or as part of collaborative efforts with laboratories elsewhere. In this way, the following areas are discussed: 1) molecular identification of fungal pathogens; 2) molecular and clinical epidemiology on fungal pathogens of prevalence in the region; 3) cell biology; 4) transcriptome, genome, molecular taxonomy and phylogeny; 5) immunology; 6) vaccines; 7) new and experimental antifungals.

  • [Show abstract] [Hide abstract]
    ABSTRACT: La caspofungine est une échinocandine prescrite pour le traitement des infections fongiques invasives causées par Candida sp. et Aspergillus sp. Le but de cette étude est d’évaluer le degré de sensibilité à la caspofungine de Candida sp., isolé à partir d’hémocultures dans l’état du Ceará (Brésil) par la méthode de microdilution. Trente-trois souches de Candida sp. ont été sélectionnées pour le test (sept C. albicans, neuf C. tropicalis et 17 C. parapsilosis) ; ces souches sont le plus souvent isolées dans des infections fongiques en Ceará. Les résultats des tests de sensibilité par microdilution peuvent être lus à 24 ou 48 heures après les tests, sans compromettre les interprétations du test. C. parapsilosis montre les CMI les plus élevées comparativement à celles de C. albicans et C. tropicalis pour la caspofungine.
    Journal de Mycologie Médicale/Journal of Medical Mycology 12/2011; · 0.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Paracoccidioides brasiliensis is the etiologic agent of paracoccidioidomycosis (PCM), the most prevalent systemic mycosis that is geographically confined to Latin America. The pro-inflammatory cytokine IL-1β that is mainly derived from the activation of the cytoplasmic multiprotein complex inflammasome is an essential host factor against opportunistic fungal infections; however, its role in infection with a primary fungal pathogen, such as P. brasiliensis, is not well understood. In this study, we found that murine bone marrow-derived dendritic cells responded to P. brasiliensis yeast cells infection by releasing IL-1β in a spleen tyrosine kinase (Syk), caspase-1 and NOD-like receptor (NLR) family member NLRP3 dependent manner. In addition, P. brasiliensis-induced NLRP3 inflammasome activation was dependent on potassium (K+) efflux, reactive oxygen species production, phagolysosomal acidification and cathepsin B release. Finally, using mice lacking the IL-1 receptor, we demonstrated that IL-1β signaling has an important role in killing P. brasiliensis by murine macrophages. Altogether, our results demonstrate that the NLRP3 inflammasome senses and responds to P. brasiliensis yeast cells infection and plays an important role in host defense against this fungus.
    PLoS Neglected Tropical Diseases 12/2013; 7(12):e2595. · 4.49 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The compound oenothein B (OenB), which is isolated from the leaves of Eugenia uniflora, a Brazilian Cerrado plant, interferes with Paracoccidioides yeast cell morphology and inhibits 1,3-beta-D-glucan synthase (PbFKS1) transcript accumulation, which is involved in cell wall synthesis. In this work we examined the gene expression changes in Paracoccidioides yeast cells following OenB treatment in order to investigate the adaptive cellular responses to drug stress. We constructed differential gene expression libraries using Representational Difference Analysis (RDA) of Paracoccidioides yeast cells treated with OenB for 90 and 180 min. Treatment for 90 min resulted in the identification of 463 up-regulated expressed sequences tags (ESTs) and 104 down-regulated ESTs. For the 180 min treatment 301 up-regulated ESTs and 143 down-regulated were identified. Genes involved in the cell wall biosynthesis, such as GLN1, KRE6 and FKS1, were found to be regulated by OenB. Infection experiments in macrophages corroborated the in vitro results. Fluorescence microscopy showed increased levels of chitin in cells treated with OenB. The carbohydrate polymer content of the cell wall of the fungus was also evaluated, and the results corroborated with the transcriptional data. Several other genes, such as those involved in a variety of important cellular processes (i.e., membrane maintenance, stress and virulence) were found to be up-regulated in response to OenB treatment. The exposure of Paracoccidioides to OenB resulted in a complex altered gene expression profile. Some of the changes may represent specific adaptive responses to this compound in this important pathogenic fungus.
    BMC Microbiology 10/2013; 13(1):227. · 2.98 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014